A Functional Connection between pRB and Transforming Growth Factor β in Growth Inhibition and Mammary Gland Development

REFERENCES

• Balsitis, S., F. Dick, D. Lee, L. Farrell, R. K. Hyde, A. E. Griep, N. Dyson, and P. F. Lambert. 2005. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo. J. Virol. 79:11392–11402.
   PubMedGoogle Scholar
• Binne, U. K., M. K. Classon, F. A. Dick, W. Wei, M. Rape, W. G. Kaelin, Jr., A. M. Naar, and N. J. Dyson. 2007. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell Biol. 9:225–232.
   PubMed Web of Science ®Google Scholar
• Bottinger, E. P., J. L. Jakubczak, D. C. Haines, K. Bagnall, and L. M. Wakefield. 1997. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res. 57:5564–5570.
   PubMedGoogle Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Burkhart, D. L., and J. Sage. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer 8:671–682.
   PubMed Web of Science ®Google Scholar
• Chan, H. M., L. Smith, and N. B. La Thangue. 2001. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Oncogene 20:6152–6163.
   PubMedGoogle Scholar
• Chen, T. T., and J. Y. J. Wang. 2000. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function. Mol. Cell. Biol. 20:5571–5580.
   PubMed Web of Science ®Google Scholar
• Clarke, A., E. Maandag, M. van Roon, N. van der Lugt, M. van der Valk, M. Hooper, A. Berns, and H. te Riele. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359:328–330.
   PubMed Web of Science ®Google Scholar
• Classon, M., S. R. Salama, C. Gorka, R. Mulloy, P. Braun, and E. E. Harlow. 2000. Combinatorial roles for pRB, p107 and p130 in E2F-mediated cell cycle control. Proc. Natl. Acad. Sci. USA 97:10820–10825.
   PubMed Web of Science ®Google Scholar
• Datta, P. K., M. C. Blake, and H. L. Moses. 2000. Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta-induced physical and functional interactions between smads and Sp1. J. Biol. Chem. 275:40014–40019.
   PubMed Web of Science ®Google Scholar
• Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X. F. Wang. 1995. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545–5549.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and D. M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275–283.
   PubMed Web of Science ®Google Scholar
• Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
   PubMed Web of Science ®Google Scholar
• Dick, F. A., E. Sailhamer, and N. J. Dyson. 2000. Mutagenesis of the pRB pocket domain reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20:3715–3727.
   PubMedGoogle Scholar
• Donovan, J., and J. Slingerland. 2000. Transforming growth factor-beta and breast cancer, Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res. 2:116–124.
   PubMed Web of Science ®Google Scholar
• D'Souza, S. J., A. Pajak, K. Balazsi, and L. Dagnino. 2001. Ca2+ and BMP-6 signaling regulate E2F during epidermal keratinocyte differentiation. J. Biol. Chem. 276:23531–23538.
   PubMed Web of Science ®Google Scholar
• Dunaief, J. L., B. E. Strober, S. Guha, P. A. Khavari, K. Alin, J. Luban, M. Begemann, G. R. Crabtree, and S. P. Goff. 1994. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119–130.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Dyson, N., P. Guida, K. Munger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J. Virol. 66:6893–6902.
   PubMed Web of Science ®Google Scholar
• Ewan, K. B., H. A. Oketch-Rabah, S. A. Ravani, G. Shyamala, H. L. Moses, and M. H. Barcellos-Hoff. 2005. Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am. J. Pathol. 167:409–417.
   PubMedGoogle Scholar
• Ewan, K. B., G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff. 2002. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am. J. Pathol. 160:2081–2093.
   PubMed Web of Science ®Google Scholar
• Fleisch, M. C., C. A. Maxwell, and M. H. Barcellos-Hoff. 2006. The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer 13:379–400.
   PubMedGoogle Scholar
• Foster, R. F., J. M. Thompson, and S. J. Kaufman. 1987. A laminin substrate promotes myogenesis in rat skeletal muscle cultures: analysis of replication and development using antidesmin and anti-BrdUrd monoclonal antibodies. Dev. Biol. 122:11–20.
   PubMedGoogle Scholar
• Furukawa, Y., S. Uenoyama, M. Ohta, A. Tsunoda, J. D. Griffin, and M. Saito. 1992. Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J. Biol. Chem. 267:17121–17127.
   PubMed Web of Science ®Google Scholar
• Gadd, M., C. Pisc, J. Branda, V. Ionescu-Tiba, Z. Nikolic, C. Yang, T. Wang, G. M. Shackleford, R. D. Cardiff, and E. V. Schmidt. 2001. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Cancer Res. 61:8811–8819.
   PubMedGoogle Scholar
• Geng, Y., and R. A. Weinberg. 1993. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315–10319.
   PubMed Web of Science ®Google Scholar
• Geng, Y., Q. Yu, E. Sicinska, M. Das, R. T. Bronson, and P. Sicinski. 2001. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc. Natl. Acad. Sci. USA 98:194–199.
   PubMed Web of Science ®Google Scholar
• Gorska, A. E., R. A. Jensen, Y. Shyr, M. E. Aakre, N. A. Bhowmick, and H. L. Moses. 2003. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am. J. Pathol. 163:1539–1549.
   PubMedGoogle Scholar
• Gorska, A. E., H. Joseph, R. Derynck, H. L. Moses, and R. Serra. 1998. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ. 9:229–238.
   PubMedGoogle Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., and D. Beach. 1994. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371:257–261.
   PubMed Web of Science ®Google Scholar
• Hao, H., P. Ropraz, V. Verin, E. Camenzind, A. Geinoz, M. S. Pepper, G. Gabbiani, and M. L. Bochaton-Piallat. 2002. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler. Thromb. Vasc. Biol. 22:1093–1099.
   PubMed Web of Science ®Google Scholar
• Hautmann, M. B., C. S. Madsen, and G. K. Owens. 1997. A transforming growth factor beta (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J. Biol. Chem. 272:10948–10956.
   PubMed Web of Science ®Google Scholar
• Herrera, R. E., T. P. Makela, and R. A. Weinberg. 1996. TGFβ-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol. Biol. Cell 7:1335–1342.
   PubMedGoogle Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hojilla, C. V., I. Kim, Z. Kassiri, J. E. Fata, H. Fang, and R. Khokha. 2007. Metalloproteinase axes increase beta-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3. J. Cell Sci. 120:1050–1060.
   PubMedGoogle Scholar
• Hurford, R., D. Cobrinik, M.-H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447–1463.
   PubMed Web of Science ®Google Scholar
• Iavarone, A., and J. Massague. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387:417–422.
   PubMedGoogle Scholar
• Isaac, C. E., S. M. Francis, A. L. Martens, L. M. Julian, L. A. Seifried, N. Erdmann, U. K. Binne, L. Harrington, P. Sicinski, N. G. Berube, N. J. Dyson, and F. A. Dick. 2006. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26:3659–3671.
   PubMed Web of Science ®Google Scholar
• Jacks, T., A. Fazeli, E. Schmitt, R. Bronson, M. Goodell, and R. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature 359:295–300.
   PubMed Web of Science ®Google Scholar
• Joseph, H., A. E. Gorska, P. Sohn, H. L. Moses, and R. Serra. 1999. Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 10:1221–1234.
   PubMedGoogle Scholar
• Kaartinen, V., J. W. Voncken, C. Shuler, D. Warburton, D. Bu, N. Heisterkamp, and J. Groffen. 1995. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:415–421.
   PubMed Web of Science ®Google Scholar
• Kobayashi, T., H. M. Kronenberg, and J. Foley. 2005. Reduced expression of the PTH/PTHrP receptor during development of the mammary gland influences the function of the nipple during lactation. Dev. Dyn. 233:794–803.
   PubMedGoogle Scholar
• Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumor-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375:506–510.
   PubMed Web of Science ®Google Scholar
• Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90:770–774.
   PubMed Web of Science ®Google Scholar
• Lai, A., B. K. Kennedy, D. A. Barbie, N. R. Bertos, X. J. Yang, M. C. Theberge, S. C. Tsai, E. Seto, Y. Zhang, A. Kuzmichev, W. S. Lane, D. Reinberg, E. Harlow, and P. E. Branton. 2001. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol. Cell. Biol. 21:2918–2932.
   PubMed Web of Science ®Google Scholar
• Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massague. 1990. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175–185.
   PubMed Web of Science ®Google Scholar
• Landis, M. W., B. S. Pawlyk, T. Li, P. Sicinski, and P. W. Hinds. 2006. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9:13–22.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y., C. Y. Chang, N. Hu, Y. C. Wang, C. C. Lai, K. Herrup, W. H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359:288–294.
   PubMed Web of Science ®Google Scholar
• Lee, J.-O., A. A. Russo, and N. P. Pavletich. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859–865.
   PubMed Web of Science ®Google Scholar
• Longworth, M. S., A. Herr, J. Y. Ji, and N. J. Dyson. 2008. RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev. 22:1011–1024.
   PubMed Web of Science ®Google Scholar
• Lukas, J., D. Parry, L. Aagarrd, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma-protein-dependent inhibition by the tumor-suppressor p16. Nature 375:503–506.
   PubMed Web of Science ®Google Scholar
• Magnaghi, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–604.
   PubMedGoogle Scholar
• Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169–178.
   PubMed Web of Science ®Google Scholar
• Massague, J. 2008. TGFβ in cancer. Cell 134:215–230.
   PubMed Web of Science ®Google Scholar
• Massague, J., and R. R. Gomis. 2006. The logic of TGFβ signaling. FEBS Lett. 580:2811–2820.
   PubMed Web of Science ®Google Scholar
• Moorehead, R. A., C. V. Hojilla, I. De Belle, G. A. Wood, J. E. Fata, E. D. Adamson, K. L. Watson, D. R. Edwards, and R. Khokha. 2003. Insulin-like growth factor-II regulates PTEN expression in the mammary gland. J. Biol. Chem. 278:50422–50427.
   PubMed Web of Science ®Google Scholar
• Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099–4105.
   PubMed Web of Science ®Google Scholar
• Muraoka, R. S., A. E. Lenferink, J. Simpson, D. M. Brantley, L. R. Roebuck, F. M. Yakes, and C. L. Arteaga. 2001. Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function. J. Cell Biol. 153:917–932.
   PubMed Web of Science ®Google Scholar
• Niculescu, A. B., III, X. Chen, M. Smeets, L. Hengst, C. Prives, and S. I. Reed. 1998. Effects of p21 Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:629–643.
   PubMed Web of Science ®Google Scholar
• Nielsen, S. J., R. Schneider, U. M. Bauer, A. J. Bannister, A. Morrison, D. O'Carroll, R. Firestein, M. Cleary, T. Jenuwein, R. E. Herrera, and T. Kouzarides. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412:561–565.
   PubMed Web of Science ®Google Scholar
• O'Gorman, S., N. A. Dagenais, M. Qian, and Y. Marchuk. 1997. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. USA 94:14602–14607.
   PubMedGoogle Scholar
• Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titre helper-free retroviuses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Pierce, D. F., Jr., M. D. Johnson, Y. Matsui, S. D. Robinson, L. I. Gold, A. F. Purchio, C. W. Daniel, B. L. Hogan, and H. L. Moses. 1993. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes Dev. 7:2308–2317.
   PubMed Web of Science ®Google Scholar
• Pietenpol, J. A., J. T. Holt, R. W. Stein, and H. L. Moses. 1990. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci. USA 87:3758–3762.
   PubMed Web of Science ®Google Scholar
• Polyak, K., J. Y. Kato, M. J. Solomon, C. J. Sherr, J. Massague, J. M. Roberts, and A. Koff. 1994. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9–22.
   PubMed Web of Science ®Google Scholar
• Proetzel, G., S. A. Pawlowski, M. V. Wiles, M. Yin, G. P. Boivin, P. N. Howles, J. Ding, M. W. Ferguson, and T. Doetschman. 1995. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:409–414.
   PubMed Web of Science ®Google Scholar
• Qin, X. Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin, Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953–964.
   PubMed Web of Science ®Google Scholar
• Rensen, S. S., P. A. Doevendans, and G. J. van Eys. 2007. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 15:100–108.
   PubMed Web of Science ®Google Scholar
• Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 9:1831–1845.
   PubMed Web of Science ®Google Scholar
• Robanus-Maandag, E., M. Dekker, M. van der Valk, M.-L. Carrozza, J.-C. Jeanny, J.-H. Dannenberg, A. Berns, and H. te Riele. 1998. p107 is a suppressor of retinoblastoma development in pRB-deficient mice. Genes Dev. 12:1599–1609.
   PubMed Web of Science ®Google Scholar
• Robertson, K. D., S. Ait-Si-Ali, T. Yokochi, P. A. Wade, P. L. Jones, and A. P. Wolffe. 2000. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25:338–342.
   PubMed Web of Science ®Google Scholar
• Robinson, G. W., K. U. Wagner, and L. Hennighausen. 2001. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20:7115–7119.
   PubMedGoogle Scholar
• Sanford, L. P., I. Ormsby, A. C. Gittenberger-de Groot, H. Sariola, R. Friedman, G. P. Boivin, E. L. Cardell, and T. Doetschman. 1997. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 124:2659–2670.
   PubMed Web of Science ®Google Scholar
• Sarker, K. P., S. M. Wilson, and S. Bonni. 2005. SnoN is a cell type-specific mediator of transforming growth factor-beta responses. J. Biol. Chem. 280:13037–13046.
   PubMedGoogle Scholar
• Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, and W. G. J. Kaelin. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95–106.
   PubMed Web of Science ®Google Scholar
• Serra, R., and M. R. Crowley. 2005. Mouse models of transforming growth factor beta impact in breast development and cancer. Endocr. Relat. Cancer 12:749–760.
   PubMedGoogle Scholar
• Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704–707.
   PubMed Web of Science ®Google Scholar
• Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359:693–699.
   PubMed Web of Science ®Google Scholar
• Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
   PubMed Web of Science ®Google Scholar
• Sicinski, P., and R. A. Weinberg. 1997. A specific role for cyclin D1 in mammary gland development. J. Mammary Gland Biol. Neoplasia 2:335–342.
   PubMedGoogle Scholar
• Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11–20.
   PubMed Web of Science ®Google Scholar
• Vandel, L., E. Nicolas, O. Vaute, R. Ferreira, S. Ait-Si-Ali, and D. Trouche. 2001. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21:6484–6494.
   PubMedGoogle Scholar
• van den Heuvel, S., and N. J. Dyson. 2008. Conserved functions of the pRB and E2F families. Nat. Rev. Mol. Cell Biol. 9:713–724.
   PubMed Web of Science ®Google Scholar
• Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334:124–129.
   PubMed Web of Science ®Google Scholar
• Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X. F. Wang, and J. Massague. 1992. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003–1014.
   PubMed Web of Science ®Google Scholar
• Yao, G., T. J. Lee, S. Mori, J. R. Nevins, and L. You. 2008. A bistable Rb-E2F switch underlies the restriction point. Nat. Cell Biol. 10:476–482.
   PubMed Web of Science ®Google Scholar
• Zhang, H. S., M. Gavin, A. Dahiya, A. A. Postigo, D. Ma, R. X. Luo, J. W. Harbour, and D. C. Dean. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101:79–89.
   PubMed Web of Science ®Google Scholar